Home/Filings/4/0001225208-25-005981
4//SEC Filing

Wood Larry L 4

Accession 0001225208-25-005981

CIK 0001099800other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:09 PM ET

Size

9.6 KB

Accession

0001225208-25-005981

Insider Transaction Report

Form 4
Period: 2025-06-16
Wood Larry L
CVP, THV Replacement
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-16$59.26/sh+8,950$530,347215,850.391 total
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2025-06-168,95044,750 total
    Exercise: $59.26From: 2020-05-08Exp: 2026-05-07Common Stock (8,950 underlying)
  • Sale

    Common Stock

    2025-06-16$75.23/sh8,950$673,268206,900.391 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    148.17
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
  • [F2]This transaction was executed in multiple trades at prices ranging from $74.8901 to $75.4400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0001440660

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:09 PM ET
Size
9.6 KB